SOAT1 and acute lymphoblastic leukemia: Moreover, the molecular characterization of T-ALL genomes based on gene expression pattern, mutation, or copy number variation disclosed additional genomic mutations in the T-cell progenitor impacting the JAK/STAT signaling pathway, protein translation, and epigenetic regulation, thus expanding the current therapeutic option against T-ALL (Girardi et al., 2017).